🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

MPNs might be rare, but you're not alone. Vijay Sankaran, MD, PhD, 2021 Progression Pilot grant awardee, says, “Scientific progress is almost always interconnected.” New discoveries push us closer to better treatments. #MPNResearch #CancerCommunity #RareDiseases

#MassGeneral physician Amy Comander MD, DipABLM was quoted in FORTUNE's article on the benefits of adding more fiber to your diet. fortune.com/well/article/d…

Nothing will kill more children than the ongoing decimation of CDC, NIH, and USAID work to lift vaccine uptake in the US and world. Child survival rose 75% in the last 50 years. Vaccines account for 40% of that. Measles vax alone was 60% of the benefit. thelancet.com/journals/lance…

New manuscript published in Blood Global Hematology with recommendations for myelofibrosis management in Latin America. Congratulations to all authors. ASH Georgia Cancer Center sciencedirect.com/science/articl…

Thrilled to see this in press finally! We show very low rates of cGVHD with rux-post-HCT in MDS and AML. Thank you Incyte for supporting this work! sciencedirect.com/science/articl… #MGH

How I treat patients with low-risk polycythemia vera who require cytoreduction | Blood | American Society of Hematology ashpublications.org/blood/article/…

Thrilled to see this published! Incredible to see this go from Dr. Ravid's lab when Orly Leiva, MD was working with her, through the development of this trial. PXS-5505 is safe, well tolerated and shows promise in helping advanced myelofibrosis haematologica.org/haematologica/…

This is so cool! This project was my first first author pub that wasn’t a review article and the project that led me to pursue cardioonc as a research career. From bench to bedside in 10 years! Grateful for this formative experience! link.springer.com/article/10.100…

Had a productive weekend discussing myelofibrosis with top experts. Naveen Pemmaraju, MD Gaby Hobbs Kalyan Nadiminti Krishna Gundabolu MBBS; MS Insightful exchanges on treatment advances and patient care. Grateful for the collaboration! #Myelofibrosis #MPNsm

Great work by Orly Leiva, MD! - pHTN, especially w/o left heart ds = higher MF and leukemia progression. Further research is needed to define the role of ECHOs in MPN care. haematologica.org/newsletter/v1/…

🔥New Pub Haematologica 🔥 This was a multi-cntr study of #MPNsm with #echofirst from NYU Grossman School of Medicine & Mass General Cancer Center. We found an assoc between PH and heme progression. See below for a thread of our findings! #cardioonc haematologica.org/article/view/1…

👉👉👉Please join us for our PER MPN educational session happening soon ! #ASCO25 Rami komrokji Gaby Hobbs Naveen Pemmaraju, MD #MPNSM

#ASCO25 #Ph_pos_ALL phase 1 study presented by Dr Marlise R. Luskin MD, MSCE Asciminib+Dasatinib+Prednisone followed by blinatumomab is safe and effective in achieving deep molecular remission. #leusm

#ASCO25 #mpnsm #IMproveMF trial presented by Dr. John Mascarenhas Imetelstat combined with stable dose of Jakafi. No significant inc in cytopenia. Symptom and SVR. Decrease in mutation burden of driver mutations.

👉👉👉Wonderful to join my fellow expert MPN colleagues for our PER #MPNSM educational event ! #meded #leusm Gaby Hobbs Rami komrokji

👉👉👉Please join us at the #ASCO25 #PlenarySession today for our group’s work on #Rusfertide #HepcidinMimetic Phase 3 Results #VERIFY for patients with Polycythemia Vera 📣 Andrew Kuykendall MD Naveen Pemmaraju, MD Kristen Pettit et al meetings.asco.org/abstracts-pres… #MPNSM ASCO

Ropeginterferon Alfa-2b Demonstrates Superior Efficacy & Safety to Anagrelide as 2L for ET - honored to have shared this yesterday during #ASCO25 ⁦Atrium Health Wake Forest Baptist⁩ Comprehensive Cancer Center ⁦⁦Levine Cancer⁩ ⁦PharmaEssentia⁩ dailynews.ascopubs.org/do/ropeginterf…

Thanks for inviting me Andrew Kuykendall MD! Always fun to talk all things #MPN!

Sustained benefits of rux+pelabresib over rux+placebo in 1L MF at week 72 in the phase 3 MANIFEST2 study. Especially good to see the difference between the arms in rates of leukemic transformation narrowing over time. #EHA25 #MPNSM

Quality over quantity of life!! Out in Journal of Clinical Oncology a prospective trial finding early palliative care during stem cell transplant isn’t just supportive... it’s transformative!! Better quality of life, less depression, mental health benefits lasting up to 6 months after treatment.